# Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy

> **NCT04429893** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Alexandria University** · enrollment: 80 (estimated)

## Conditions studied

- Cancer Breast
- Chronic Pain Syndrome

## Interventions

- **DRUG:** magnesium sulphate
- **DRUG:** bupivicaine

## Key facts

- **NCT ID:** NCT04429893
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04429893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04429893, "Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04429893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*